CTF1 and chronic kidney disease: Importantly, analysis of data from microdissected glomeruli from patients with chronic kidney disease (CKD) and healthy living donors (Ju et al., 2013) showed reduced glomerular levels of CT‐1 in a range of glomerular diseases, revealing that CT‐1 signalling is also disrupted in human glomerular disease.